Detalhe da pesquisa
1.
Impact of LS Mutation on Pharmacokinetics of Preventive HIV Broadly Neutralizing Monoclonal Antibodies: A Cross-Protocol Analysis of 16 Clinical Trials in People without HIV.
Pharmaceutics
; 16(5)2024 Apr 27.
Artigo
em Inglês
| MEDLINE | ID: mdl-38794258
2.
Application of the SLAPNAP statistical learning tool to broadly neutralizing antibody HIV prevention research.
iScience
; 26(9): 107595, 2023 Sep 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-37654470
3.
Safety and antiviral activity of triple combination broadly neutralizing monoclonal antibody therapy against HIV-1: a phase 1 clinical trial.
Nat Med
; 28(6): 1288-1296, 2022 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-35551291
4.
Safety, pharmacokinetics and antiviral activity of PGT121, a broadly neutralizing monoclonal antibody against HIV-1: a randomized, placebo-controlled, phase 1 clinical trial.
Nat Med
; 27(10): 1718-1724, 2021 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-34621054
5.
Acceptability and tolerability of repeated intramuscular electroporation of Multi-antigenic HIV (HIVMAG) DNA vaccine among healthy African participants in a phase 1 randomized controlled trial.
PLoS One
; 15(5): e0233151, 2020.
Artigo
em Inglês
| MEDLINE | ID: mdl-32469893
6.
The potential of broadly neutralizing antibodies for HIV prevention.
J Int AIDS Soc
; 27(5): e26257, 2024 May.
Artigo
em Inglês
| MEDLINE | ID: mdl-38757844
7.
Adeno-associated virus vectored immunoprophylaxis to prevent HIV in healthy adults: a phase 1 randomised controlled trial.
Lancet HIV
; 6(4): e230-e239, 2019 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-30885692
8.
HIV virologic failure and its predictors among HIV-infected adults on antiretroviral therapy in the African Cohort Study.
PLoS One
; 14(2): e0211344, 2019.
Artigo
em Inglês
| MEDLINE | ID: mdl-30721233
9.
Viral complementation allows HIV-1 replication without integration.
Retrovirology
; 5: 60, 2008 Jul 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-18613957
10.
High incidence of type 1 diabetes mellitus during or shortly after treatment with pegylated interferon alpha for chronic hepatitis C virus infection.
Liver Int
; 28(1): 39-46, 2008 Jan.
Artigo
em Inglês
| MEDLINE | ID: mdl-18031478
11.
Inflammatory markers neopterin and alanine aminotransferase in HCV patients treated with HCV NS3.4A protease inhibitor telaprevir (VX-950) and/or peginterferon alfa-2a.
Scand J Gastroenterol
; 43(9): 1122-7, 2008.
Artigo
em Inglês
| MEDLINE | ID: mdl-18609142
12.
Prediction of virologic response in difficult-to-treat chronic hepatitis C patients during high-dose interferon induction therapy.
Scand J Gastroenterol
; 43(7): 857-69, 2008.
Artigo
em Inglês
| MEDLINE | ID: mdl-18584525
13.
Low-level HCV viraemia after initial response during antiviral therapy: transcription-mediated amplification predicts treatment failure.
Antivir Ther
; 12(3): 423-7, 2007.
Artigo
em Inglês
| MEDLINE | ID: mdl-17591033
14.
Hepatitis B Virus Incidence and Risk Factors Among Human Immunodeficiency Virus-1 Negative Men Who Have Sex With Men in Kenya.
Open Forum Infect Dis
; 4(1): ofw253, 2017.
Artigo
em Inglês
| MEDLINE | ID: mdl-28695141
15.
Clinical performance of the new rRoche COBAS TaqMan HCV Test and High Pure System for extraction, detection and quantitation of HCV RNA in plasma and serum.
Antivir Ther
; 11(1): 95-103, 2006.
Artigo
em Inglês
| MEDLINE | ID: mdl-16518965
16.
Diagnostic Accuracy of the HemoCue Hb 301, STAT-Site MHgb and URIT-12 Point-of-Care Hemoglobin Meters in a Central Laboratory and a Community Based Clinic in Durban, South Africa.
PLoS One
; 11(4): e0152184, 2016.
Artigo
em Inglês
| MEDLINE | ID: mdl-27046200
17.
Mass drug administration for trachoma: how long is not long enough?
PLoS Negl Trop Dis
; 9(3): e0003610, 2015 Mar.
Artigo
em Inglês
| MEDLINE | ID: mdl-25799168
18.
Hepatitis C virus RNA quantification by the COBAS AmpliPrep/COBAS TaqMan System: averages do not tell the whole story.
J Clin Virol
; 39(4): 326-7, 2007 Aug.
Artigo
em Inglês
| MEDLINE | ID: mdl-17600765
19.
University students and HIV in Namibia: an HIV prevalence survey and a knowledge and attitude survey.
J Int AIDS Soc
; 15(1): 9, 2012 Feb 22.
Artigo
em Inglês
| MEDLINE | ID: mdl-22353579
20.
Factor XIII Val34Leu mutation accelerates the development of fibrosis in patients with chronic hepatitis B and C.
Hepatol Res
; 42(7): 668-76, 2012 Jul.
Artigo
em Inglês
| MEDLINE | ID: mdl-22385348